Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$332,978
New position
Shares Held
2,900
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#162
of 238 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026PenderFund Capital Management Ltd. holds $2,724,879 across 7 Biotechnology names. ACLX ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
41,100 | $594,306 | |
| 2 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
205,000 | $580,150 | |
| 3 | DAWN |
Day One Biopharmaceuticals, Inc.
|
26,800 | $574,592 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
6,850 | $398,327 | |
| 5 | ACLX |
Arcellx, Inc.
This page
|
2,900 | $332,978 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
47,500 | $237,975 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
490 | $6,551 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $332,978 | 2,900 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||